These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8585114

  • 21. Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood.
    MacFarlane GD, Scheller DG, Ersfeld DL, Shaw LM, Venkatarmanan R, Sarkozi L, Mullins R, Fox BR.
    Clin Chem; 1999 Sep; 45(9):1449-58. PubMed ID: 10471647
    [Abstract] [Full Text] [Related]

  • 22. Specific and sensitive measurement of FK506 and its metabolites in blood and urine of liver-graft recipients.
    Christians U, Braun F, Schmidt M, Kosian N, Schiebel HM, Ernst L, Winkler M, Kruse C, Linck A, Sewing KF.
    Clin Chem; 1992 Oct; 38(10):2025-32. PubMed ID: 1382896
    [Abstract] [Full Text] [Related]

  • 23. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
    Tszyrsznic W, Borowiec A, Pawlowska E, Jazwiec R, Zochowska D, Bartlomiejczyk I, Zegarska J, Paczek L, Dadlez M.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun 01; 928():9-15. PubMed ID: 23584041
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An immunoassay for the measurement of sirolimus.
    Jones K, Saadat-Lajevard S, Lee T, Horwatt R, Hicks D, Johnston A, Holt DW.
    Clin Ther; 2000 Jun 01; 22 Suppl B():B49-61. PubMed ID: 10823373
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of the Relationship Between Concentrations of Tacrolimus Metabolites, 13-O-Demethyl Tacrolimus and 15-O-Demethyl Tacrolimus, and Clinical and Biochemical Parameters in Kidney Transplant Recipients.
    Zegarska J, Hryniewiecka E, Zochowska D, Samborowska E, Jazwiec R, Maciej K, Nazarewski S, Dadlez M, Paczek L.
    Transplant Proc; 2018 Sep 01; 50(7):2235-2239. PubMed ID: 30177142
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoring.
    Hermida J, Tutor JC.
    Clin Lab; 2003 Sep 01; 49(9-10):471-4. PubMed ID: 14572203
    [Abstract] [Full Text] [Related]

  • 31. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
    Saint-Marcoux F, Debord J, Parant F, Labalette M, Kamar N, Rostaing L, Rousseau A, Marquet P.
    Ther Drug Monit; 2011 Apr 01; 33(2):171-7. PubMed ID: 21383655
    [Abstract] [Full Text] [Related]

  • 32. Measurement of AM19 and other cyclosporine metabolites in the blood of liver transplant patients with stable liver function.
    Liu WT, Levy GA, Wong PY.
    Ther Drug Monit; 1995 Oct 01; 17(5):479-86. PubMed ID: 8585111
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Fingerprick blood samples can be used to accurately measure tacrolimus levels by tandem mass spectrometry.
    Webb NJ, Roberts D, Preziosi R, Keevil BG.
    Pediatr Transplant; 2005 Dec 01; 9(6):729-33. PubMed ID: 16269043
    [Abstract] [Full Text] [Related]

  • 35. Comparison of CEDIA FK506 assay with HPLC/MS/MS in a large cohort of pediatric patients.
    Lower DR, Cropcho L, Rosendorff A.
    Am J Clin Pathol; 2013 Jun 01; 139(6):788-92. PubMed ID: 23690122
    [Abstract] [Full Text] [Related]

  • 36. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
    Hashi S, Masuda S, Kikuchi M, Uesugi M, Yano I, Omura T, Yonezawa A, Fujimoto Y, Ogawa K, Kaido T, Uemoto S, Matsubara K.
    Transplant Proc; 2014 Apr 01; 46(3):758-60. PubMed ID: 24767342
    [Abstract] [Full Text] [Related]

  • 37. Comparison of 4 Commercial Immunoassays Used in Measuring the Concentration of Tacrolimus in Blood and Their Cross-Reactivity to Its Metabolites.
    Shigematsu T, Suetsugu K, Yamamoto N, Tsuchiya Y, Masuda S.
    Ther Drug Monit; 2020 Jun 01; 42(3):400-406. PubMed ID: 31568181
    [Abstract] [Full Text] [Related]

  • 38. HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients.
    Firdaous I, Hassoun A, Otte JB, Reding R, Squifflet JP, Besse T, Wallemacq PE.
    Clin Chem; 1995 Sep 01; 41(9):1292-6. PubMed ID: 7544705
    [Abstract] [Full Text] [Related]

  • 39. CYP3A5 genotype does not influence the blood concentration of tacrolimus measured with the Abbott immunoassay.
    Moreton M, Fredericks S, McKeown DA, Shiferaw EW, MacPhee IA, Johnston A, Holt DW.
    Clin Chem; 2005 Nov 01; 51(11):2214-5. PubMed ID: 16244311
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.